EP3421093A1 - Liquid composition for wash of scalp and hair, or for wash of skin comprising piroctone olamine - Google Patents

Liquid composition for wash of scalp and hair, or for wash of skin comprising piroctone olamine Download PDF

Info

Publication number
EP3421093A1
EP3421093A1 EP18178512.2A EP18178512A EP3421093A1 EP 3421093 A1 EP3421093 A1 EP 3421093A1 EP 18178512 A EP18178512 A EP 18178512A EP 3421093 A1 EP3421093 A1 EP 3421093A1
Authority
EP
European Patent Office
Prior art keywords
composition
wash
skin
scalp
tensides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP18178512.2A
Other languages
German (de)
French (fr)
Other versions
EP3421093B1 (en
EP3421093B8 (en
Inventor
Hans Algeskog
Henrik Lindau
Sten Ottander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daxxin AB
Original Assignee
Daxxin AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daxxin AB filed Critical Daxxin AB
Priority to PL18178512T priority Critical patent/PL3421093T3/en
Publication of EP3421093A1 publication Critical patent/EP3421093A1/en
Publication of EP3421093B1 publication Critical patent/EP3421093B1/en
Application granted granted Critical
Publication of EP3421093B8 publication Critical patent/EP3421093B8/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/044—Suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Abstract

A liquid composition for use in the treatment of psoriasis or ichtyosis in the scalp, or for treatment of psoriasis or ichtyosis on other skin than the one on the scalp. The composition is used for wash of scalp or skin, and comprising at least:
□ 13,5 - 24,0 % Mild wash tensides,
□ 1,0 - 4,7 % Guar HydroxrypropyltrimoniumCloride,
□ 0,3 - 1,0 % Piroctone Olamine
The composition is preferably washed away with liquid after use, but is preferably left to work for 2 - 5 minutes before it is washed away.

Description

    Technical area:
  • The present invention relates to a liquid composition for wash of scalp and hair or for wash of skin and aimed at alleviating dermatological disorder or disease, the composition comprising at least:
    • 13,5 - 24,0 % Mild wash tensides,
    • 1,0 - 4,7 % Guar HydroxrypropyltrimoniumCloride,
    • 0,3 - 1,0 % Piroctone Olamine
    The composition is aimed at use to alleviate psoriasis in the scalp or on other skin, to alleviate eczema or to alleviate ichtyosis. Background:
  • There are a number of dermatological diseases, that are difficult or impossible to remedy. The treatment therefore aims at alleviating the symptoms or the troubles for a very long time, possibly for an entire life. Of course it is important that the symptoms are indeed alleviated and that the treatment itself is not trying. If so the life quality of the affected is raised.
    Psoriasis is such a skin disease. It gives red spots, that scales off and sometimes itches. The outermost layer of the skin is called the epidermis. Outermost in it the horn layer is situated, that is made up of dead skin cells. From beneath new skin cells in a steady pace replaces old dead skin cells that falls off. In a psoriasis condition the cells in the epidermis are formed more quickly than usual, and the cells do not fall off one by one but flakes off in big flakes. Furthermore there is an inflammation in the skin that increases the blood circulation to redden the skin and warm it. Psoriasis often comes in so called relaps. It implies periods with small or no problems and periods when the disease flushes up and the rashes becomes bigger.
  • The most common form of psoriasis shows round, a couple of centimeter big flaking rashes, so called plaques. It is therefore called plaque - psoriasis. The skin disorders can be located anywhere on the whole body, but most often on the elbows, the knees, the lower part of the back and the scalp. The coverage of the body can vary from only less than a percent up to the whole or almost the whole body surface. In a mild form of psoriasis, that can be seen as a skin disorder, it can be sufficient to take a bath and to apply a thick layer of softening lotion or ointment several times a week.
  • In a more severe form of psoriasis, that should be regarded as a skin disease, a more effective treatment is often wanted using prescribed lotions and ointments. These products can comprise D-vitamin like substances, that have few side effects. But most times these products comprise a strong cortisone, that works fast but has side effects. To reduce the troubles regular treatment is needed for several weeks. After the treatment the rashes will often come back after only a couple of weeks. The side effects make these substances not suitable to use for pregnant and nursing women. There are also compositions that comprise a number of other ingredients to try to decrease the side effects of the strong cortisone.
    and dampen its negative influence on the skin. EP 2 705 847 gives an example of a night cream that in addition to a strong cortisone also comprises a tar extract, an antibiotic component and lanolin, och preferably also almond oil. Furthermore it is preferable to use a day cream that comprises skin caring and skin calming vegetabilic oils. Combined with washing of the skin this makes three different treatment steps. After 3 months of treatment each one of 3 subjects were three from psoriasis symptoms for almost 1 year before the symptoms started again.
    To treat psoriasis in the scalp a de-scaling anti-dandruff shampoo or a solvent that comprises cortisone is used. The treatment takes away all dead skin or scales. These compositions are fairly aggresive to the skin and are therefore often combined with a sothening and skin calming lotion. But in spite of complicated multi-stage treatments the problems as a rule come back after only a few weeks. This also applies for other skin disorders or skin diseases as eczema on the skin or ichtyosis. There is a need for compositions and treatments that can provide good results at the same time as they are less aggresive to the skin and give less side effects than the current compositions At the same time the treatments should preferably be easy to perform for the sick person.
    • Summary:
  • The present invention intends to decrease one or more of the above stated weaknesses by providing a liquid composition for washing of the scalp and hair or for washing of skin and aimed at alleviating dermatological disorder or disease, the composition comprising at least:
    • □ 13,5 - 24,0 % Mild wash tensides,
    • □ 1,0 - 4,7 % Guar HydroxrypropyltrimoniumCloride,
    • □ 0,3 - 1,0 % Piroctone Olamine
  • Further the liquid composition can preferably be washed away with liquid, and preferably after it has been applied for 2 - 5 minutes before it is washed away with liquid. The use of the composition is preferably made where the dermatological disorder or disease is psoriasis on the scalp or on other skin. The use of the composition is preferably made where the dermatological disorder or disease is eczema on the skin or ichtyosis.
    • Description of preferred embodiments:
  • The liquid composition according to the current invention comprises at least:
    • □ 13,5 - 24,0 % Mild wash tensides,
    • □ 1,0 - 4,7 % Guar HydroxrypropyltrimoniumCloride, Below called Guar
    • □ 0,3 - 1,0 % Piroctone Olamine
  • The use of mild wash tensides, results in less dry out of the skin, compared to a use of sulfates, which is the most usual. The wash results in that only a part of the dead skin cells or dead skin flakes is washed away, and definitely not all of them as a deflaking shampoo does. This provides a wash more gentle for the skin. Furthermore Guar comprises substances that are conditioning by being softening and remoisturising
    Furthermore Piroctone Olamine is an active ingrediens that slows down the growth of the fungus malassezia furfur. To much of this fungus creates or contributes to scalp problems The liquid composition washes gently to not dry out the skin, and it is softening and remoisturing and it slows the growth of fungus. All this makes the present composition much more gentle than earlier compositions that did take away all dead skin cells and all fungus. After use of such an earlier composition a complementary cream treatment was required to remoisturize and soften. But still the treatment with an earlier composition and lotion is fairly aggresive. The new liquid composition enables a treatment that is much milder to the skin, so the skin is not irritated. Also it enables a treatment in a single stage in stead of normally in 2 or 3 stages. You can see it as a change of paradigm into a more gentle and simple treatment. Tests made show that this especially is the case if the amount of Guar is increased to 1,5% - 3,5%, or preferably 1,5% - 3,0%. At the same time the amount of Piroctone Oleamine should be increased to 0,5% - 0;97%, or preferably 0,7% - 0,97%. In the tests made no known side effects were noted.
    The mild wash tensides are one or more of the following wash tensides:
    • □ Disodium Laureth Sulfosuccinate
    • □ Lauryl Gluciside
    • □ Disodium Undecylenamido Mea Sulfosuccinate
    • □ Cocamidpropyl Betain
    They have been chosen as they are kind to the skin and do not dry the skin out.
  • Use of a liquid composition according to the present invention, where the dermatological disorder or disease is psorias in the scalp and the composition is a shampoo or similar. Psoriasis in the scalp is very irritating for the affected person. The affected person has a need to keep his hair aqnd scalp clean. Of course it is an advantage if the wash can be made with a mild shampoo, that does not irritate the scalp, and leads to itch and pruritus. The composition according to the invention can in more severe cases be combined with aq cortisone drug, but in many cases the composition can give a good result when used alone, see studies below. The treatment of the affected person is particularly simple in this case. He only changes his earlier shampoo to a shampoo according to the invention
  • Use of a composition according to the present invention, where the dermatological disorder or disease is psoriasis on other skin than the skin of the scalp and the composition is a shower gel, shower cream or similar. As the composition is mild to the skin and without known side effects it can be used over the whole body and replace a usual shower cream. Limited tests with the composition used at psoriasis on other skin than in the scalp have showed good results. Test persons for Psoriasis in the scalp that also have psoriasis on other skin have simply noticed that the composition works well for both types of psoriasis, which is perhaps not so strange.
  • Use of a composition according to the present invention where the dermatological disorder or disease is eczema in the scalp or on other skin and the composition is a shampoo, shower cream or similar. As the composition is mild to the skin and without known side effects it can be used over the whole body and replace a usual shower cream. Limited tests have shown good results for the type of eczema Seborroic eczema, i.e. Eczema in the scalp.
  • Use of a composition according to the present invention, where the dermatological disorder or disease is ichtyosis on the scalp or on other skin and the composition is a shampoo, a shower cream or similar. Limited test with the composition for this aim have given good results for more than 10 persons having the diagnosis ichtyosis on the scalp. Use of a composition according to the present invention, where the composition is washed away with liquid after use. Normally the liquid is water, but of course additives can be used, e.g. Almond oil. Please observe that made studies have used water for wash away.
    Use of a composition as above for wash of scalp or skin, whereby the composition is left to work for 2 - 5 minutes before it is washed away with liquid. This last use has been considered the best and has also been recommended to the subjects in the made studies.
    • Studies:
  • A study has been made for persons with the diagnosis psoriasis in the scalp. More than 50 persons have been using a shampoo according to the invention for 3 months. They have filled in a test protocol before and after the 3 months treatment. In short the result show that approximately 60% of the subjects experienced an improvement through a decrease of their symptoms noted as better or much better. This concerned symptoms of the four types itching, reddening, scaling and scratch marks/ wounds.
  • A limited study of more than 10 persons having ichtyosis on the scalp shows that a clear majority experienced a distinct reduction of their symptoms after a 7 week treatment with the shampoo according to the invention. Everybody would also continue using the shampoo.

Claims (10)

  1. A liquid composition for use in the treatment of psoriasis in the scalp. The composition is a shampoo or similar for wash of scalp and hair, and the composition comprises at least:
    □ 13,5 - 24,0 % Mild wash tensides,
    □ 1,0 - 4,7 % Guar HydroxrypropyltrimoniumCloride,
    □ 0,3 - 1,0 % Piroctone Olamine
  2. A liquid composition for use in the treatment of psoriasis on other skin than the one on the scalp. The composition is a shower gel, shower soap or similar for wash of skin, and the composition comprises at least:
    □ 13,5 - 24,0 % Mild wash tensides,
    □ 1,0 - 4,7 % Guar HydroxrypropyltrimoniumCloride,
    □ 0,3 - 1,0 % Piroctone Olamine
  3. A liquid composition for use in the treatment of ichtyosis in the scalp. The composition is a shampoo or similar for wash of scalp and hair, and the composition comprises at least:
    □ 13,5 - 24,0 % Mild wash tensides,
    □ 1,0 - 4,7 % Guar HydroxrypropyltrimoniumCloride,
    □ 0,3 - 1,0 % Piroctone Olamine
  4. A liquid composition for use in the treatment of ichtyosis on other skin than the one on the scalp. The composition is a shower gel, shower soap or similar for wash of skin, and the composition comprises at least:
    □ 13,5 - 24,0 % Mild wash tensides,
    □ 1,0 - 4,7 % Guar HydroxrypropyltrimoniumCloride,
    □ 0,3 - 1,0 % Piroctone Olamine
  5. A composition according to any of claims 1-4, where the composition comprises at least:
    - 15 - 20 % Mild wash tensides,
    - 1,5 - 3,5 % Guar HydroxrypropyltrimoniumCloride,
    - 0,5 - 0,97 % Piroctone Olamine
  6. A composition according to claim 5, where the composition comprises at least:
    - 15 - 20 % Mild wash tensides,
    - 1,5 - 3,0 % Guar HydroxrypropyltrimoniumCloride,
    - 0,7 - 0,97 % Piroctone Olamine
  7. A composition according to any of claims 1-6, where the mild wash tensides consist of one or more of the following wash tensides:
    □ Disodium Laureth Sulfosuccinate
    □ Lauryl Gluciside
    □ Disodium Undecylenamido Mea Sulfosuccinate
    □ Cocamidpropyl Betain
  8. A composition according to any of claims 1 - 7, where the composition is aimed at being washed away with liquid after use.
  9. A composition according to any of claims 1 - 8, where the composition is aimed at being left to work for 2 - 5 minutes before it is washed away with liquid.
  10. A composition according to any of claims 1 - 9, where the composition is aimed at being the only treatment stage.
EP18178512.2A 2017-06-27 2018-06-19 Liquid composition for wash of scalp and hair, or for wash of skin comprising piroctone olamine Active EP3421093B8 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL18178512T PL3421093T3 (en) 2017-06-27 2018-06-19 Liquid composition for wash of scalp and hair, or for wash of skin comprising piroctone olamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1700132 2017-06-27

Publications (3)

Publication Number Publication Date
EP3421093A1 true EP3421093A1 (en) 2019-01-02
EP3421093B1 EP3421093B1 (en) 2020-09-23
EP3421093B8 EP3421093B8 (en) 2020-12-23

Family

ID=62712865

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18178512.2A Active EP3421093B8 (en) 2017-06-27 2018-06-19 Liquid composition for wash of scalp and hair, or for wash of skin comprising piroctone olamine

Country Status (7)

Country Link
US (1) US10668054B2 (en)
EP (1) EP3421093B8 (en)
DK (1) DK3421093T3 (en)
ES (1) ES2834905T3 (en)
HU (1) HUE051704T2 (en)
LT (1) LT3421093T (en)
PL (1) PL3421093T3 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021099117A1 (en) * 2019-11-21 2021-05-27 Unilever Ip Holdings B.V. A cosmetic composition
WO2021224118A1 (en) * 2020-05-08 2021-11-11 Unilever Ip Holdings B.V. Personal care compositions comprising a metal piroctone complex

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2694694A1 (en) * 1992-08-13 1994-02-18 Thorel Jean Noel Compsn for treating psoriasis partic of the scalp - can be used as a shampoo and is effective, odourless and free of side effects
WO1998052518A1 (en) * 1997-07-02 1998-11-26 Neutrogena Corporation Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat seborrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof
US7262158B1 (en) * 1999-07-01 2007-08-28 Johnson & Johnson Companies, Inc. Cleansing compositions comprising a liquid silicone and ester mixture
EP2705847A1 (en) 2012-09-05 2014-03-12 PSoriasis+Creams Sweden AB Composition for treating psoriasis
KR101395727B1 (en) * 2013-10-11 2014-05-15 주식회사 스킨네이처 Cosmetic composition for preventing and improving skin disease comprising piroctone olamine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133899A1 (en) 2000-10-31 2003-07-17 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal cleansing compositions that contain surfactants, co-surfactants, water insoluble solids and/or liquids and cationic conditioning polymers
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
ITMI20031941A1 (en) 2003-10-09 2005-04-10 Sinclair Pharmaceuticals Ltd TOPICAL PHARMACEUTICAL COMPOSITIONS FOR DERMATITIS TREATMENT
DE102007059705A1 (en) * 2007-12-10 2009-06-25 Henkel Ag & Co. Kgaa Hair cleanser with surfactant / care combination
ES2627549T3 (en) 2013-04-25 2017-07-28 Unilever N.V. Cleaning compositions with improved suspension and distribution properties

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2694694A1 (en) * 1992-08-13 1994-02-18 Thorel Jean Noel Compsn for treating psoriasis partic of the scalp - can be used as a shampoo and is effective, odourless and free of side effects
WO1998052518A1 (en) * 1997-07-02 1998-11-26 Neutrogena Corporation Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat seborrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof
US7262158B1 (en) * 1999-07-01 2007-08-28 Johnson & Johnson Companies, Inc. Cleansing compositions comprising a liquid silicone and ester mixture
EP2705847A1 (en) 2012-09-05 2014-03-12 PSoriasis+Creams Sweden AB Composition for treating psoriasis
KR101395727B1 (en) * 2013-10-11 2014-05-15 주식회사 스킨네이처 Cosmetic composition for preventing and improving skin disease comprising piroctone olamine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 17 May 2017 (2017-05-17), ANONYMOUS: "Anti Dandruff Soothing Shampoo", XP055515245, retrieved from www.gnpd.com Database accession no. 4824273 *
DATABASE GNPD [online] MINTEL; 18 September 2015 (2015-09-18), DAXXIN: "Triple Acting Shampoo", XP055515251, retrieved from www.gnpd.com Database accession no. 3456165 *
DATABASE WPI Week 201446, 1 November 2014 Derwent World Patents Index; AN 2014-J95640, XP002785720, "Composition useful as cosmetic e.g. for moisturizing skin, and treating e.g. inflammations, acne, atopic dermatitis and psoriasis, comprises piroctone olamine, allantoin, dipotassium glycyrrhizinate, alpha-bisabolol and tocopherol acetate" *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021099117A1 (en) * 2019-11-21 2021-05-27 Unilever Ip Holdings B.V. A cosmetic composition
CN114727945A (en) * 2019-11-21 2022-07-08 联合利华知识产权控股有限公司 Cosmetic composition
WO2021224118A1 (en) * 2020-05-08 2021-11-11 Unilever Ip Holdings B.V. Personal care compositions comprising a metal piroctone complex

Also Published As

Publication number Publication date
PL3421093T3 (en) 2021-03-08
EP3421093B1 (en) 2020-09-23
DK3421093T3 (en) 2020-12-07
ES2834905T3 (en) 2021-06-21
EP3421093B8 (en) 2020-12-23
US20180369218A1 (en) 2018-12-27
US10668054B2 (en) 2020-06-02
LT3421093T (en) 2020-12-10
US20190321347A9 (en) 2019-10-24
HUE051704T2 (en) 2021-03-29

Similar Documents

Publication Publication Date Title
US6482442B1 (en) Substance mixture for topical application comprising olive oil and honey
RU2320362C2 (en) Proanthocyanidin-containing topical pharmaceutical compositions for treatment of dermatitis
CN102716511B (en) Antibacterial and hypoallergenic spray
KR100960054B1 (en) Hair cosmetic composition for improving stste of scalp and preventing fall-out of hair
EP3421093B1 (en) Liquid composition for wash of scalp and hair, or for wash of skin comprising piroctone olamine
KR101888957B1 (en) Natural shampoo composition comprising White Dandelion extract
CN108514572A (en) Chinese medicine composition, extract and preparation a kind of anti-inflammatory and that repair skin barrier
CN112472654A (en) Amino acid Chinese herbal medicine shampoo for treating seborrheic dermatitis and seborrheic alopecia
Trüeb North American virginian witch hazel (Hamamelis virginiana): based scalp care and protection for sensitive scalp, red scalp, and scalp burn-out
JP6842794B2 (en) Topical skin preparation
KR101065608B1 (en) Andrographolide or Andrographis paniculata extract containing composition having anti-itching effect
EP1980241A2 (en) Wet wipes with vitex agnus castus extract for feminine personal care
US8475852B2 (en) Topical therapeautic composition and palliative treatment method
CN107822929B (en) Scalp care essential oil capable of effectively relieving itching
CN104435281B (en) Itching relieving spray and preparation method thereof
CN109432211B (en) Traditional Chinese medicine composition for psoriasis and eczema, external medicine thereof, and preparation methods and application of traditional Chinese medicine composition and external medicine
EP3373897A1 (en) Skin care composition
KR20090091970A (en) Herb medicine extracts containing body cleanser composition
CN110946777A (en) Allantoin nano emulsion for feet and preparation method thereof
US8741360B2 (en) Topical therapeutic composition and palliative treatment method
JP3138399B2 (en) Body rinse bath agent
CN110251415A (en) A kind of antiallergic reparation facial mask containing polypeptide
WO2017197535A1 (en) Product for the therapy and prevention of burnout syndrome of the scalp and the skin
DE102021118540A1 (en) Composition of traditional Chinese medicine and method of preparation
CN106491512A (en) A kind of bio protease new life essence cream

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190704

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61Q 19/00 20060101ALI20200401BHEP

Ipc: C11D 3/48 20060101ALI20200401BHEP

Ipc: A61Q 5/02 20060101ALI20200401BHEP

Ipc: C11D 1/12 20060101ALI20200401BHEP

Ipc: C11D 1/66 20060101ALI20200401BHEP

Ipc: A61P 17/06 20060101AFI20200401BHEP

Ipc: A61Q 19/10 20060101ALI20200401BHEP

Ipc: C11D 1/90 20060101ALI20200401BHEP

Ipc: A61P 31/10 20060101ALI20200401BHEP

Ipc: A61K 8/49 20060101ALI20200401BHEP

Ipc: A61K 8/04 20060101ALI20200401BHEP

Ipc: A61K 31/4412 20060101ALI20200401BHEP

Ipc: A61Q 5/00 20060101ALI20200401BHEP

Ipc: C11D 1/86 20060101ALI20200401BHEP

Ipc: A61K 8/73 20060101ALI20200401BHEP

INTG Intention to grant announced

Effective date: 20200429

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602018008017

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1315794

Country of ref document: AT

Kind code of ref document: T

Effective date: 20201015

GRAT Correction requested after decision to grant or after decision to maintain patent in amended form

Free format text: ORIGINAL CODE: EPIDOSNCDEC

REG Reference to a national code

Ref country code: CH

Ref legal event code: PK

Free format text: BERICHTIGUNG B8

REG Reference to a national code

Ref country code: FI

Ref legal event code: FGE

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20201201

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: SK

Ref legal event code: T3

Ref document number: E 35764

Country of ref document: SK

REG Reference to a national code

Ref country code: EE

Ref legal event code: FG4A

Ref document number: E020039

Country of ref document: EE

Effective date: 20201127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200923

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201224

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201223

REG Reference to a national code

Ref country code: NO

Ref legal event code: T2

Effective date: 20200923

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200923

REG Reference to a national code

Ref country code: HU

Ref legal event code: AG4A

Ref document number: E051704

Country of ref document: HU

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200923

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210125

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200923

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200923

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210123

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2834905

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20210621

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602018008017

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200923

26N No opposition filed

Effective date: 20210624

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200923

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20230315

Year of fee payment: 6

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230516

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200923

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NO

Payment date: 20230622

Year of fee payment: 6

Ref country code: NL

Payment date: 20230616

Year of fee payment: 6

Ref country code: LT

Payment date: 20230524

Year of fee payment: 6

Ref country code: IE

Payment date: 20230619

Year of fee payment: 6

Ref country code: FR

Payment date: 20230619

Year of fee payment: 6

Ref country code: EE

Payment date: 20230620

Year of fee payment: 6

Ref country code: DK

Payment date: 20230615

Year of fee payment: 6

Ref country code: DE

Payment date: 20230621

Year of fee payment: 6

Ref country code: CZ

Payment date: 20230519

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20230607

Year of fee payment: 6

Ref country code: SK

Payment date: 20230523

Year of fee payment: 6

Ref country code: PL

Payment date: 20230519

Year of fee payment: 6

Ref country code: LV

Payment date: 20230620

Year of fee payment: 6

Ref country code: LU

Payment date: 20230616

Year of fee payment: 6

Ref country code: HU

Payment date: 20230602

Year of fee payment: 6

Ref country code: FI

Payment date: 20230620

Year of fee payment: 6

Ref country code: AT

Payment date: 20230621

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20230616

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20230620

Year of fee payment: 6

Ref country code: GB

Payment date: 20230619

Year of fee payment: 6

Ref country code: ES

Payment date: 20230703

Year of fee payment: 6

Ref country code: CH

Payment date: 20230702

Year of fee payment: 6